NCT01913665

Brief Summary

The aim of this study is to asses the effect of Bifidobacterium lactis and Inulin on functional constipation in children

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 1, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Last Updated

August 7, 2013

Status Verified

August 1, 2013

Enrollment Period

1.2 years

First QC Date

July 30, 2013

Last Update Submit

August 5, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • to compare defecation frequency between baseline and 4 th week of treatment

    baseline and 4th week of intervention

Study Arms (4)

B.Lactis

ACTIVE COMPARATOR

children with functional constipation

Other: B.lactis

Inulin

ACTIVE COMPARATOR

children with functional constipation

Other: Inulin

B.Lactis+ınulin

ACTIVE COMPARATOR

children with functional constipation

Other: B.Lactis +Inulin

plasebo

PLACEBO COMPARATOR

children with functional constipation

Other: Placebo

Interventions

B.Lactis
InulinOTHER
Inulin
B.Lactis+ınulin
PlaceboOTHER
plasebo

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • children with functional constipation over 3 years age
  • below 18 years of age

You may not qualify if:

  • Chronic gastrointestinal disease,
  • hirschsprung disease,
  • celiac disease,
  • hypothyroids,
  • neurological deficit,
  • constipation treatment receiving children will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Inulin

Intervention Hierarchy (Ancestors)

StarchGlucansBiopolymersPolymersMacromolecular SubstancesDietary CarbohydratesCarbohydratesFructansPolysaccharides

Central Study Contacts

Makbule Eren, Associate professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

July 30, 2013

First Posted

August 1, 2013

Study Start

September 1, 2013

Primary Completion

December 1, 2014

Last Updated

August 7, 2013

Record last verified: 2013-08